Hypercholesteremia

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Astellas
AstellasChina - Shenyang
1 program
1
atorvastatin, LipitorPhase 41 trial
Active Trials
NCT00408382Completed50
Conception
ConceptionCA - Berkeley
1 program
LimicolN/A1 trial
Active Trials
NCT01354327CompletedEst. May 2011
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
Pattern of Statins Use in CataloniaN/A1 trial
Active Trials
NCT01477944Completed180,723Est. Feb 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstraZenecaPattern of Statins Use in Catalonia
ConceptionLimicol

Clinical Trials (3)

Total enrollment: 180,773 patients across 3 trials

NCT00408382Astellasatorvastatin, Lipitor

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

50 patients
Phase 4Completed
NCT01477944AstraZenecaPattern of Statins Use in Catalonia

Pattern of Statins Use in Catalonia

Start: Feb 2012Est. completion: Feb 2012180,723 patients
N/ACompleted
NCT01354327ConceptionLimicol

Effects of Limicol on LDL-cholesterol

Start: Dec 2008Est. completion: May 2011
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space